8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2020 / Phase II double-blind randomized placebo-controlled trial
In a 6-month trial, 44 participants with peripheral artery disease were randomized to consume a daily cocoa beverage (15 g cocoa, 75 mg epicatechin) or a placebo. Adjusting for smoking, race, and BMI, cocoa improved 6-minute walk distance by 42.6 m (90% CI, +22.2 to +∞; P=0.005) at 2.5 hours after a final beverage, and by 18.0 m (90% CI, -1.7 to +∞; P=0.12) at 24 hours post-beverage compared to placebo. Calf muscle biopsies showed cocoa improved mitochondrial cytochrome c oxidase activity (P=0.013), increased capillary density (P=0.014), improved perfusion (P=0.098), and reduced central nuclei (P=0.033).
McDermott MM, Criqui MH, Domanchuk K, et al. Circ Res, 2020. PMID 32078436
2020 / Randomized controlled trial
Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).
Thaung Zaw JJ, Howe PRC, Wong RHX Nutrients, 2020. PMID 32244933
2020 / Uncontrolled pre-post trial with young active reference group
Sixteen middle-aged, untrained participants completed 10 weeks of full-body resistance training twice weekly, with biopsies taken pre- and post-training, and baseline comparisons made to 15 trained college-aged men. In the middle-aged participants, resistance training increased muscle NAD+ (+127%, p<0.001), NADH (+99%, p=0.002), global SIRT activity (+13%, p=0.036), NAMPT protein (+15%, p=0.014), and citrate synthase activity (+183%, p<0.001). Pre-training NAD+ and NADH were lower in middle-aged participants than young participants (p<0.05), but were similar post-training (p>0.10). The increase in citrate synthase activity was significantly associated with increases in muscle NAD+ (r2=0.592, p=0.001).
Lamb DA, Moore JH, Mesquita PHC, et al. Aging (Albany NY), 2020. PMID 32369778
2020 / Single-blind randomized controlled trial
A single-blind randomized trial evaluated 60 elderly subjects assigned to receive 2 g lavender teabags twice daily as a decoction for 2 weeks or to an untreated control group. After the intervention, depression scores were significantly lower in the intervention group compared to the control group (16.33 ± 1.49 vs. 18.33 ± 1.84, P < 0.001). Mean differences between intervention and control groups were -2.00 (95% CI: -2.86, -1.13) for depression, -6.40 (95% CI: -9.43, -3.36) for state anxiety, and -4.13 (95% CI: -7.66, -0.60) for trait anxiety.
Bazrafshan MR, Jokar M, Shokrpour N, et al. Complement Ther Med, 2020. PMID 32444033
2020 / Randomized, double-blind, placebo-controlled crossover trial
In the RESHAW trial, postmenopausal women were randomized to receive resveratrol (75 mg twice daily) or placebo in a 24-month crossover design. After 12 months of resveratrol compared to placebo, bone mineral density increased in the lumbar spine (+0.016 ± 0.003 g/cm2) and neck of femur (+0.005 ± 0.002 g/cm2), accompanied by a 7.24% reduction in C-terminal telopeptide type-1 collagen levels. The femoral neck bone mineral density increase improved T-scores (+0.070 ± 0.018) and lowered 10-year fracture risk, with larger effects observed in women with poorer bone biomarker status or those taking vitamin D plus calcium.
Wong RH, Thaung Zaw JJ, Xian CJ, et al. J Bone Miner Res, 2020. PMID 32564438
2020 / Pilot double-blind randomized placebo-controlled trial
Patients with mild Alzheimer's disease were randomized to receive three 350 mg erinacine A-enriched Hericium erinaceus mycelia (EAHE) capsules per day (5 mg/g erinacine A) or placebo for 49 weeks following a 3-week screening period. After 49 weeks, the EAHE group showed significant improvement in MMSE score, a significant difference in IADL score compared to placebo, and a significant decrease in CASI score was noted only in the placebo group. The EAHE group also achieved significantly better contrast sensitivity and showed differences in biomarkers and neuroimaging ADC values compared to placebo. Four subjects dropped out due to abdominal discomfort, nausea, and skin rash, with no other adverse events reported.
Li IC, Chang HH, Lin CH, et al. Front Aging Neurosci, 2020. PMID 32581767
2020 / Randomized controlled trial (2 x 2 factorial)
In the VITAL-DEP randomized clinical trial, 18,353 participants aged 50 years or older were assigned to vitamin D3 (2000 IU/d) or placebo for a median duration of 5.3 years. Risk of depression or clinically relevant depressive symptoms did not significantly differ between the vitamin D3 group (12.9/1000 person-years) and placebo (13.3/1000 person-years; HR 0.97, 95% CI 0.87 to 1.09; P = .62). There were also no significant differences in depression incidence, recurrence, or change in PHQ-8 mood scores over time (mean difference 0.01 points, 95% CI -0.04 to 0.05 points).
Okereke OI, Reynolds CF, Mischoulon D, et al. JAMA, 2020. PMID 32749491
2020 / Randomized, double-blind, placebo-controlled crossover trial
In a 24-month randomized, double-blind, placebo-controlled crossover trial, 125 healthy postmenopausal women received resveratrol (75 mg twice daily) or placebo to assess effects on well-being and cerebrovascular function. Resveratrol supplementation significantly reduced composite pain score (P < 0.001), especially in overweight participants, and this reduction was associated with improved cerebrovascular responsiveness to hypercapnia (R = -0.329, P = 0.014). Somatic menopausal symptoms (P = 0.024) and general well-being (P = 0.010) were also improved.
Thaung Zaw JJ, Howe PRC, Wong RHX Menopause, 2020. PMID 32881835
2020 / Multicenter, randomized, double-blind, placebo-controlled trial
One hundred menopausal Korean women were randomly assigned to receive either 400 mg/day of porcine placental extract (PPE) or a placebo for 12 weeks. While the Kupperman Index (KMI) decreased in both groups, the overall difference between groups was not statistically significant. However, KMI decreased significantly more with PPE than placebo in women with BMI 23 kg/m2 or higher (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05) and in early menopausal women (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). Estradiol levels also increased significantly in the PPE group at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05).
Lee JY, Lee C, Yoon SH, et al. Taiwan J Obstet Gynecol, 2020. PMID 32917317
2020 / Randomised controlled trial
Older adults (n=1567) were randomized to twice-weekly HIIT (n=400), MICT (n=387), or following national physical activity guidelines (control, n=780) for five years. All-cause mortality did not differ between the control group and the combined MICT and HIIT group. Compared with controls (4.7% observed mortality), absolute risk reduction was 1.7 percentage points after HIIT (HR 0.63, 95% CI 0.33 to 1.20) and absolute increased risk was 1.2 percentage points after MICT (HR 1.24, 95% CI 0.73 to 2.10). Comparing HIIT to MICT, absolute risk reduction was 2.9 percentage points (HR 0.51, 95% CI 0.25 to 1.02). Controls performed more of their physical activity as HIIT than the MICT group did, achieving an exercise dose between MICT and HIIT.
Stensvold D, Viken H, Steinshamn SL, et al. BMJ, 2020. PMID 33028588
2020 / Randomized two-group parallel-arm study
A randomized parallel-arm study evaluated the effects of 16 weeks of either 85 g or 250 g of Ataulfo mango intake on facial wrinkles and erythema in healthy postmenopausal women with Fitzpatrick skin type II or III. In the 85 g group, deep wrinkle severity decreased significantly after 8 weeks (p = 0.007) and 16 weeks (p = 0.03) compared to baseline, while cheek erythema increased (p = 0.04). In contrast, the 250 g group showed significant increases after 16 weeks in average wrinkle severity (p = 0.049), average wrinkle length (p = 0.007), fine wrinkle severity (p = 0.02), and emerging wrinkle severity (p = 0.02).
Fam VW, Holt RR, Keen CL, et al. Nutrients, 2020. PMID 33158079
2020 / Randomized, double-blinded, placebo-controlled clinical trial
A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.
Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304
2019 / Randomised, double-blinded, placebo-controlled crossover trial
A randomized, double-blinded, placebo-controlled crossover trial evaluated the effects of 20 mg/day oral saffron versus placebo for 3 months each in 100 adults with mild/moderate age-related macular degeneration. Mean BCVA improved by 0.69 letters (p = 0.001) and mean-pooled mfERG latency decreased by 0.17 ms (p = 0.04) on saffron compared to placebo. In participants also taking AREDS supplements, mean BCVA improved by 0.73 letters (p = 0.006) and mfERG response density improved by 2.8% (p = 0.038). Adverse events did not differ significantly between groups (p > 0.10).
Broadhead GK, Grigg JR, McCluskey P, et al. Graefes Arch Clin Exp Ophthalmol, 2019. PMID 30343354
2019 / Clinical trial protocol
Researchers initiated a clinical trial protocol recruiting 5,000 subjects aged 45-65 to evaluate popular antiaging practices, including diet, drugs, supplements, and exercise. Participants provide blood samples to measure methylation age at the beginning, middle, and end of a 2-year period, with the primary endpoint being the difference in methylation age over 2 years. The exploratory study aims to detect whether certain combinations of strategies synergize to achieve age retardation of 25% or more.
Mitteldorf J Rejuvenation Res, 2019. PMID 30345885
2019 / Double-blind randomized controlled trial
Older adults underwent 12 weeks of aerobic exercise training (AET) while randomized double-blind to placebo (n = 26) or metformin (n = 27). Independent of treatment, AET decreased fat mass, HbA1c, fasting plasma insulin, 24-hr ambulant mean glucose, and glycemic variability. However, metformin attenuated improvements in whole-body insulin sensitivity and VO2 max, and abrogated increases in skeletal muscle mitochondrial respiration. Mitochondrial protein synthesis rates were not different between treatments.
Konopka AR, Laurin JL, Schoenberg HM, et al. Aging Cell, 2019. PMID 30548390
2019 / Randomized controlled trial
Fifty-six ambulatory women aged 50 or older with daily urinary incontinence were randomized to a 3-month Iyengar-based yoga program or a muscle stretching and strengthening control program; both received self-management education. Over 3 months, total incontinence frequency decreased by an average of 76% in the yoga group versus 56% in controls (P = .07). Stress incontinence frequency decreased by 61% in the yoga group compared to 35% in controls (P = .045), while changes in urgency incontinence frequency showed no significant difference between groups. High retention (89%) was observed with no adverse events directly attributable to the interventions.
Huang AJ, Chesney M, Lisha N, et al. Am J Obstet Gynecol, 2019. PMID 30595143
2019 / Randomized, double-blind, placebo-controlled trial
A randomized, double-blind, placebo-controlled study evaluated whether toothpaste enriched with 100 µg cyanocobalamin/g could improve vitamin B12 status in 103 elderly subjects over 3 months. In the 92 participants who completed the trial, post-intervention serum vitamin B12 concentrations were higher in the B12 group than placebo [368 (123) vs. 295 (123) pmol/L; p=0.005]. Changes from baseline were significantly greater in the B12 group for vitamin B12 [54 (74) vs. 3 (60) pmol/L, p<0.001], holoTC [21 (34) vs. 2 (32) pmol/L, p=0.007], and tHcy [-0.9 (2.3) vs. 0.3 (1.9) µmol/L, p=0.010]. No side effects were observed.
Zant A, Awwad HM, Geisel J, et al. Aging Clin Exp Res, 2019. PMID 30680547
2019 / Randomized, double-blind trial
In a randomized, double-blind trial, adults aged 45 to 79 with symptomatic knee osteoarthritis consumed either 40 g of freeze-dried blueberry powder (n = 33) or placebo powder (n = 30) daily for four months. The blueberry group experienced significant decreases in WOMAC total score, pain, stiffness, and difficulty performing daily activities (p < 0.05), whereas improvements in total score and daily activities were not seen with placebo. In the blueberry group, normal walking pace single support percentage increased for both limbs (p ≤ 0.007) and double support percentage decreased (p ≤ 0.003). No significant changes were observed in plasma concentrations of TNF-α, IL-1β, IL-6, IL-10, IL-13, MMP-3, MMP-13, and MCP-1 in either group, though trends were observed for IL-13 and MCP-1 in the blueberry group.
Du C, Smith A, Avalos M, et al. Nutrients, 2019. PMID 30699971
2019 / Randomized placebo-controlled double-blind trial
Elderly individuals with vitamin D deficiency were randomized to receive either 100,000 IU/15 days of cholecalciferol (n = 19) or placebo (n = 19) for 3 months, followed by influenza vaccination and immune evaluation 28 days later. Serum 25-(OH)D increased in the supplementation group (20.7 ± 5.7 to 44.3 ± 8.6 ng/mL, p < 0.001). Supplementation led to lower plasma levels of TNFα (p = 0.040) and IL-6 (p = 0.046), higher TGFβ (p = 0.0028), and a lower Th1/Th2 ratio prior to vaccination (0.12 ± 0.05 vs. 0.18 ± 0.05, p = 0.039). However, no differences were found between groups for antibody titers, serum cathelicidin levels, or ROS production.
Goncalves-Mendes N, Talvas J, Dualé C, et al. Front Immunol, 2019. PMID 30800121
2019 / Randomized, placebo-controlled, double-blind trial
Twenty-two chronic stroke patients underwent an 8-week rehabilitation exercise intervention (3 sessions/week, 120 min/session) and were randomly assigned to ingest either soymilk (n=11) or a placebo beverage (n=11) immediately post-exercise. Compared with placebo, immediate soymilk ingestion significantly improved hand grip strength (p=0.021), 8-feet walking speed (p=0.019), walking performance per unit lean mass (p=0.024), and 6-minute walk performance (p=0.016). However, changes in lean mass and the total score for the short physical performance battery (SPPB) did not differ between the groups.
Liao YH, Chen CN, Hu CY, et al. NeuroRehabilitation, 2019. PMID 30856124
2019 / Randomized single-blind, controlled crossover trial
In a randomized single-blind, controlled crossover study of 22 healthy volunteers, researchers evaluated the effects of a 5-day intervention with raw or cooked leaves of Brassica carinata on telomerase activity in CD4+ and CD8+ T cells. Both preparations produced a marginal increase in telomerase activity in CD4+ cells compared to baseline. In CD8+ cells, intervention with the cooked material led to a significant 25% increase in telomerase activity (p < 0.05). Whether this intervention has long-term effects on telomere extension in specific T cell subsets remains to be determined.
Tran HTT, Schreiner M, Schlotz N, et al. Nutrients, 2019. PMID 30959753
2019 / Randomized crossover clinical trial
In a randomized crossover trial, 49 prediabetic subjects consumed an isocaloric control diet or a pistachio-supplemented diet (including 57 g pistachios/d) for 4 months each, separated by a 2-week washout. Compared with the control diet, the pistachio diet reduced oxidative damage to DNA (mean: -3.5%; 95% CI: -8.07%, 1.05%; P = 0.009). It also significantly upregulated expression of TERT (164%, P = 0.043) and WRAP53 (53%, P = 0.001). Changes in TERT expression were negatively correlated with changes in fasting plasma glucose and HOMA-IR.
Canudas S, Hernández-Alonso P, Galié S, et al. Am J Clin Nutr, 2019. PMID 31051499
2019 / Two-phase double-blind randomized clinical trial
A two-phase, double-blind randomized clinical trial evaluated the effects of consuming a flavonoid-rich cocoa beverage daily for up to 12 weeks. In the initial study (60 subjects aged 55-70), the flavonoid-rich group showed improvements in glycemia, triglyceridemia, HDL, LDL, the triglyceridemia/HDL index, oxidative markers, the Up and Go test, skeletal muscle index, and quality of life compared to placebo or non-flavonoid cocoa. In the follow-up study (74 subjects aged 65-90), flavonoid treatment significantly improved metabolic, oxidative stress, and inflammatory endpoints, along with positive effects on physical performance, frailty indicators, and quality of life compared with the non-flavonoid beverage.
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, et al. J Gerontol A Biol Sci Med Sci, 2019. PMID 31056655
2019 / Two-arm randomized controlled trial
A 16-week randomized controlled trial compared a lacto-ovo-vegetarian diet rich in omega-3 fatty acids to one rich in extra-virgin olive oil (EVO) in postmenopausal women. Among 40 women who completed the study, the omega-3 group (n=18) achieved significantly greater improvements than the EVO group (n=22) in the Kupperman index (Δ = -11.4±9.8 vs. -5.9±8.2; p=0.045) and hot flashes (Δ = -3.3±3.4 vs. -1.3±2.6; p=0.04). A marginally significant improvement was noted for nervousness (Δ = -1.7±1.7 vs. -0.8±1.5; p=0.07), with no significant differences in secondary anthropometric or biohumoral measures.
Rotolo O, Zinzi I, Veronese N, et al. Endocr Metab Immune Disord Drug Targets, 2019. PMID 31132980